Adverse events of different chemotherapy regimens in the first-line treatment of patients with advanced or metastatic urothelial cancer: A systematic review and network meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Adverse events of different chemotherapy regimens in the first-line treatment of patients with advanced or metastatic urothelial cancer: A systematic review and network meta-analysis of randomized controlled trials

Published:2021-06 Issue:3 Volume:48 Page:181-192
ISSN:0093-7754
Container-title:Seminars in Oncology
language:en
Short-container-title:Seminars in Oncology

Author:

Laukhtina Ekaterina^ORCID,Mori Keiichiro^ORCID,Mostafaei Hadi,Merseburger Axel S.,Nyirady Peter,Moschini Marco,Quhal Fahad,Pradere Benjamin,Motlagh Reza Sari,Enikeev Dmitry,Shariat Shahrokh F.

Funder

European Association of Urology

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference28 articles.

1. EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort†[Formula presented]: Under the Auspices of the EAU-ESMO Guidelines Committees;Witjes;Eur Urol,2020

2. EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer. Edn. presented at the EAU Annual Congress Amsterdam 2020;Witjes,2020

3. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: Checklist and explanations;Hutton;Ann Intern Med,2015

4. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials;Higgins;BMJ,2011

5. Automating network meta-analysis;van Valkenhoef;Res Synth Methods,2012

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reevaluating the role of platinum-based chemotherapy in the evolving treatment landscape for patients with advanced urothelial carcinoma;The Oncologist;2024-08-21

2. Melatonin exhibits partial protective effects against gemcitabine- and cisplatin-induced kidney and reproductive injuries in mice;Aging;2023-12-14

3. Avelumab First-Line Maintenance Therapy: Managing Patients With Advanced Urothelial Carcinoma;Oncology Nursing Forum;2023-01-26

4. Targeted Inhibition of O-Linked β-N-Acetylglucosamine Transferase as a Promising Therapeutic Strategy to Restore Chemosensitivity and Attenuate Aggressive Tumor Traits in Chemoresistant Urothelial Carcinoma of the Bladder;Biomedicines;2022-05-18